Jomaa Pharma GmbH

Ownership
Private
Employees
-
Market Cap
-
Website

Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria

First Posted Date
2014-07-24
Last Posted Date
2015-06-15
Lead Sponsor
Jomaa Pharma GmbH
Target Recruit Count
100
Registration Number
NCT02198807

Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children

First Posted Date
2011-11-03
Last Posted Date
2011-11-03
Lead Sponsor
Jomaa Pharma GmbH
Target Recruit Count
52
Registration Number
NCT01464138
Locations
🇲🇿

Centro de Investigacao em Saude da Manhica, Maputo, Mozambique

Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults

Phase 2
Conditions
Interventions
First Posted Date
2011-11-03
Last Posted Date
2011-11-03
Lead Sponsor
Jomaa Pharma GmbH
Target Recruit Count
43
Registration Number
NCT01464125
Locations
🇹🇭

Mahidol University, Bangkok, Thailand

Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2009-10-27
Last Posted Date
2011-09-27
Lead Sponsor
Jomaa Pharma GmbH
Target Recruit Count
40
Registration Number
NCT01002183
Locations
🇹🇭

Mahidol University, Bangkok, Thailand

© Copyright 2024. All Rights Reserved by MedPath